Journal of Neuroimmunology
Volume 122, Issue 1 , Pages 55-64 , January 2002

GROα/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation—a role in Alzheimer's disease?

Received 16 July 2000 ,Revised 24 October 2001 ,Accepted 24 October 2001.

References 

  1. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J. Immunol. 1999;162:1685–1691
  2. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, et al.  Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 1992;149:2358–2366
  3. Araujo DM, Cotman CW. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 1993;600:49–55
  4. Bacon K. Analysis of signal transduction following lymphocyte activation by chemokines. Methods Enzymol. 1997;288:340–361
  5. Bacon KB, Flores-Romo L, Life PF, Taub DD, Premack BA, Arkinstall SJ. IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J. Immunol. 1995;154:3654–3666
  6. Bacskai BJ, Xia MQ, Strickland DK, Rebeck GW, Hyman BT. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 2000;97:11551–11556
  7. Baggiolini M, Dewald B, Moser B. Human chemokines—an update. (Review) Annu. Rev. Immunol. 1997;15:675–705
  8. Balentien E, Mufson BE, Shattuck RL, Derynck R, Richmond A. Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene. 1991;6:1115–1124
  9. Barsig J, Flesch IE, Kaufmann SH. Macrophages and hepatocytic cells as chemokine producers in murine listeriosis. Immunobiology. 1998;199:87–104
  10. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993;336:417–424
  11. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al.  A new class of membrane-bound chemokine with a CX(3)C motif. Nature. 1997;385:640–644
  12. Becker S, Quay J, Koren HS, Haskill JS. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am. J. Physiol. 1994;266:L278–L286
  13. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999;286:1358–1362
  14. Bozic CR, Kolakowski LF, Gerard NP, Garcia-Rodriguez C, von Uexkull-Guldenband C, Conklyn MJ, et al.  Expression and biologic characterization of the murine chemokine KC. J. Immunol. 1995;154:6048–6057
  15. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 2000;12:78–85
  16. Carroll SL, Frohnert PW. Expression of JE (monocyte chemoattractant protein-1) is induced by sciatic axotomy in wild type rodents but not in C57BL/Wld(s) mice. J. Neuropathol. Exp. Neurol. 1998;57:915–930
  17. Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 1999;68:965–1014
  18. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos P. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 2000;20(RC87):1–5
  19. Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, Cen B, et al.  Beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4. J. Biol. Chem. 2000;275:2479–2485
  20. Coughlan CM, McManus CM, Sharron M, Gao ZY, Murphy D, Jaffer S, et al.  Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience. 2000;97:591–600
  21. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J. Cell Biol. 1995;131:495–508
  22. Desbaillets I, Diserens AC, Detribolet N, Hamou MF, Vanmeir EG. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis and angiogenesis. J. Exp. Med. 1997;186:1201–1212
  23. Ehrlich LC, Hu S, Sheng WS, Sutton RL, Rockswold GL, Peterson PK, et al.  Cytokine regulation of human microglial cell IL-8 production. J. Immunol. 1998;160:1944–1948
  24. Flugel A, Hager G, Horvat A, Spitzer C, Singer GMA, Graeber MB, et al.  Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow Metab. 2001;21:9–76
  25. Gitter BD, Cox LM, Rydel RE, May PC. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc. Natl. Acad. Sci. U. S. A. 1995;92:10738–10741
  26. Gleichmann M, Gillen C, Czardybon M, Bosse F, Greiner-Petter R, Auer J, et al. Cloning and characterization of SDF-1 gamma a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur. J. Neurosci. 2000;12:1857–1866
  27. Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 1997;409:57–62
  28. Harrison JK, Barber CM, Lynch KR. cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors. Neurosci. Lett. 1994;169:85–89
  29. Harrison JK, Jiang Y, Chen SZ, Xia YY, Maciejewski D, McNamara RK, et al.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998;95:10896–10901
  30. He JL, Chen YZ, Farzan M, Choe HY, Ohagen A, Gartner S, et al.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 1997;385:645–649
  31. Hilmas C, Pereira EFR, Alkondon M, Rossoulpour A, Schwarcz R, Albuquerque EX. The brain metablolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 Nicotinic receptor expression: physiopathological implications. J. Neurosci. 2001;21:7463–7473
  32. Hofman FM, Chen P, Jeyaseelan R, Incardona F, Fisher M, Zidovetzki R. Endothelin-1 induces production of the neutrophil chemotactic factor interleukin-8 by human brain-derived endothelial cells. Blood. 1998;92:3064–3072
  33. Hofman FM, Chen P, Incardona F, Zidovetzki R, Hinton DR. HIV-1 TAT protein induces the production of interleukin-8 by human brain-derived endothelial cells. J. Neuroimmunol. 1999;94:28–39
  34. Horuk R, Martin AW, Wang ZX, Schweitzer L, Gerassimides A, Guo HH, et al.  Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 1997;158:2882–2890
  35. Hyman BT, Elvhage TE, Reiter J. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Am. J. Pathol. 1994;144:565–572
  36. Illenberger S, Zheng-Fischhofer Q, Preuss U, Stamer K, Baumann K, Trinczek B, et al.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell. 1998;9:1495–1512
  37. Janabi N, Hau I, Tardieu M. Negative feedback between prostaglandin and α and β-chemokine synthesis in human microglial cells and astrocytes. J. Immunol. 1999;162:1701–1706
  38. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, et al.  cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 1999;19:7486–7494
  39. Jones SA, Moser B, Thelen M. A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2. Chemokine mediated activation of p42/p44 MAP-kinase (ERK-2). FEBS Lett. 1995;364:211–214
  40. Kornhauser JM, Greenberg ME. A kinase to remember: dual roles for MAP kinase in long-term memory. [comment] Neuron. 1997;18:839–842
  41. Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, Wang Q, et al.  CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 1997;151:1035–1042
  42. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 1998;187:655–660
  43. Lipovsky MM, Gekker G, Hu S, Ehrlich LC, Hoepelman AI, Peterson PK. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J. Infect. Dis. 1998;177:260–263
  44. Liu T, Young PR, McDonnell PC, White RF, Barone FC, Feuerstein GZ. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci. Lett. 1993;164:125–128
  45. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's Sarcoma. Clin. Cancer Res. 2001;7:2693–2702
  46. Meda L, Bonaiuto C, Szendrei GI, Ceska M, Rossi F, Cassatella MA. Beta-amyloid (25–35) induces the production of interleukin-8 from human monocytes. J. Neuroimmunol. 1995;59:29–33
  47. Meier P, Evan G. Dying like flies. Cell. 1998;95:295–298
  48. Metzner B, Hofmann C, Heinermann C, Zimpfer U, Schraufsta Schopf E, Norgauer J. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in epidermoid carcinoma cells KB and A431. Oncol. Rep. 1999;6:1405–1410
  49. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 1998;95:14500–14505
  50. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al.  The consortium to establish a registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–486
  51. Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol. Rev. 1999;79:1373–1430
  52. Nguyen D, Stangel M. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglia cells. Brain Res. Dev. Brain Res. 2001;128:77–81
  53. Okiyama K, Smith DH, Gennarelli TA, Simmon RP, Leach M, McIntosh TK. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J. Neurochem. 1995;64:802–809
  54. Petersen F, Van Damme J, Flad HD, Brandt E. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release. Lymphokine Cytokine Res. 1991;10:35–41
  55. Premack BA, Schall TJ. Chemokine receptors—gateways to inflammation and infection. Nat. Med. 1996;2:1174–1178
  56. Puma C, Danik M, Quirion R, Ramon F, William S. The chemokine interleukin-8 acutely reduces Ca++ identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 2001;78:960–971
  57. Ragozzino D, Giovannelli A, Mileo AN, Limatola C, Santoni A, Eusebi F. Modulation of the neurotransmitter release in rat cerebellar neurons by GRO beta. NeuroReport. 1998;9:3601–3606
  58. Reynolds CH, Utton MA, Gibb GM, Yates A, Anderton BH. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J. Neurochem. 1997;68:1736–1744
  59. Roder HM, Eden PA, Ingram VM. Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Commun. 1993;193:639–647
  60. Sanders VJ, Pittman CA, White MC, Wang GJ, Wiley CA, Achim CL. Chemokines and receptors in HIV encephalitis. AIDS. 1998;12:1021–1026
  61. Scott CW, Spreen RC, Herman JL, Chow FP, Davison MD, Young J, et al.  Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J. Biol. Chem. 1993;268:1166–1173
  62. Shea TB, Cressman CM. The order of exposure of tau to signal transduction kinases alters the generation of “AD-like” phosphoepitopes. Cell. Mol. Neurobiol. 1999;19:223–233
  63. Shyamala V, Khoja H. Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells. Biochemistry. 1998;37:15918–15924
  64. Shyamala V, Khoja H, Moghadam M. Inhibition of adenylyl cyclase by alpha chemokines IL-8 and GRO-alpha in Chinese hamster ovary cells expressing R1 and R2 receptors. J. Interferon Cytokine Res. 1998;18:235–239
  65. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999;103:801–815
  66. Tani M, Glabinski AR, Tuohy VK, Stoler MH, Estes ML, Ransohoff RM. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 1996;148:889–896
  67. Trojanowski JQ, Lee VM. Paired helical filament tau in Alzheimer's disease. The kinase connection. Am. J. Pathol. 1994;144:449–453
  68. Trojanowski JQ, Lee VM. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 1995;9:1570–1576
  69. Trojanowski JQ, Mawal-Dewan M, Schmidt ML, Martin J, Lee VM. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites. Brain Res. 1993;618:333–337
  70. Xia MQ, Hyman BT. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. (Review) J. NeuroVirol. 1999;5:32–41
  71. Xia MQ, Hyman BT. Chemokines in the central nervous system and Alzheimer's disease. In:  Ransohoff RM editors. Universes in Delicate Balance: Chemokines in the Central Nervous System. Amsterdam: Elsevier; 2001; in press
  72. Xia MQ, Qin SX, McNamara M, Mackay CR, Hyman BT. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am. J. Pathol. 1997;150:1267–1274
  73. Xia MQ, Qin SQ, Wu LJ, Mackay CR, Hyman BT. Immunohistochemical study of CCR3 and CCR5 and their ligands in control and AD brains. Am. J. Pathol. 1998;153:31–37
  74. Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J. Neuroimmunol. 2000;108:227–235
  75. Zaballos A, Gutierrez J, Varona R, Ardavin C, Marquez G. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J. Immunol. 1999;162:5671–5675

PII: S0165-5728(01)00463-5

Journal of Neuroimmunology
Volume 122, Issue 1 , Pages 55-64 , January 2002

Article Tools

* Image Usage & Resolution